Decades of High-Stakes Experience: Philip P. Crowley brings the perspective of a counsel who has drawn on decades of experience, including his time as corporate counsel at Johnson & Johnson.
For tech and life sciences startups, a strategic plan is only as strong as the assumptions it is built upon. In the rush to capture market share or secure the next funding round, companies often rely on “best-case” projections and unverified market data.
Without clear, professionally vetted Strategic Planning Assumptions, you expose your startup to severe risks: misallocated capital, missed pivot opportunities, operational bottlenecks, and “blind-spot” failures that can drain your runway before you even reach your next milestone.
While a vision drives a startup, validated assumptions ensure the company can actually execute it. Well-developed planning assumptions define the market conditions, regulatory timelines, competitive landscapes, and resource requirements that must hold for your strategy to succeed.
These safeguards protect your burn rate, product roadmap, and investor credibility while reducing risks like over-hiring, supply chain fragility, or regulatory delays. For fast-scaling startups, relying on “gut feeling” or static spreadsheets often leads to strategic drift, investor friction, and missed exit windows.
In today’s volatile, tech-driven economy, robust assumption management is not just a corporate exercise; it is an essential risk-management tool that preserves company value, ensures alignment with the board, and supports long-term growth and successful pivots.
Strategic Planning Assumptions are the fundamental beliefs and projections that support your entire business model. Developing and reviewing these assumptions is not a “one-and-done” exercise; it is a rigorous process of identifying, quantifying, and stress-testing the variables that determine your startup’s survival.
At Crowley Law, we view these assumptions as the Strategic Compass of your organization. We move beyond simply accepting projections at face value. Instead, we construct an “Intelligence Fortress” around your roadmap by auditing market data, neutralizing internal biases, and ensuring every strategic move is anchored in legal and commercial reality.
In the venture ecosystem, your “strategic hygiene” and the logic behind your forecasts are under constant scrutiny. You face unique risks: a competitor launching a superior technology while you are locked into a three-year plan, or a sudden shift in FDA or SEC regulations that renders your primary assumption about “time-to-market” obsolete.
As your Strategic Planning and General Counsel, Crowley Law ensures that your growth hypotheses are converted into enforceable, measurable benchmarks. Our strategy focuses on “Scenario Depth,” creating multiple layers of contingency plans that make it possible to pivot quickly without losing your core investment or market position.
A custom-tailored approach to your planning assumptions provides several critical layers of protection:
Choosing where to focus your vetting efforts is a strategic decision that impacts your company’s focus and resource allocation.
Feature | Internal Assumptions | External Assumptions |
Primary Function | Capabilities, team performance, and R&D speed. | Market size, regulatory changes, and competitor moves. |
Degree of Control | High management through internal KPIs and hiring. | Low requires constant monitoring and legal foresight. |
Impact of Failure | Direct operational slowdowns or morale issues. | Fundamental business model failure or legal roadblocks. |
Best For | Scaling teams and refining product-market fit. | Global expansion and long-term exit planning. |
Strategic planning is a mosaic of legal, financial, and operational disciplines. As your Life Sciences and Tech Counsel, Crowley Law integrates these elements into a single, cohesive planning strategy.
Key components include:
The most common way startups lose momentum isn’t through a lack of effort; it’s through “optimism bias” during the planning phase, or failing to review assumptions after a major market shift. Once you have committed your capital to a specific path based on flawed data, the cost of correction grows exponentially.
Maintaining a “culture of critical review” within your leadership team is essential. Clear milestones and “assumption audits” are the first line of defense in protecting your startup’s valuation.
Key terms locked in early include:
If your product is the ship, your assumptions are the charts. Without a robust review, your startup is vulnerable to “sunk cost” thinking, continuing down a failing path because the original plan said so.
Crowley Law’s services focus on:
Most strategic failures are the result of “setting and forgetting” or relying on outdated data from a previous market cycle. In the eyes of the board, “we didn’t see it coming” is often a failure of assumption vetting.
Real-World Pitfalls to Avoid:
We don’t just “check the math”; we act as your “Strategic Guardrails.” Our firm understands that for a startup, every assumption must be a bridge to your next valuation inflection point.
Crowley Law LLC combines decades of corporate legal experience with personalized counsel tailored to the unique needs of startups. The firm is led by Philip P. Crowley, with over 45 years of experience, including prior service as corporate counsel at Johnson & Johnson, where he managed complex internal governance and licensing matters.
Crowley Law focuses on providing strategic, practical advice that helps founders and partners build strong structures, resolve conflicts, and navigate growth smoothly.
Don’t build your future on a house of cards. Validate your strategic assumptions today.
At a minimum, quarterly. High-growth or volatile sectors (like AI or Biotech) may require monthly “pulse checks.”
It is an assumption that, if proven false, would require a complete change in your business model or product.
Yes, but it must be qualified and balanced with quantitative data to avoid individual bias.
The assumption of how long it will take to get legal clearance to sell your product. It is often the most underestimated risk.
We facilitate a “Red Team” exercise where we try to break each assumption to see which one is most resilient.